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Summary
When emerging from the ribosomes, new polypeptides
need to fold properly, eventually translocate, and then as-
semble into stable, yet functionally flexible complexes.
During their lifetime, native proteins are often exposed to
stresses that can partially unfold and convert them into
stably misfolded and aggregated species, which can in turn
cause cellular damage and propagate to other cells. In an-
imal cells, especially in aged neurons, toxic aggregates
may accumulate, induce cell death and lead to tissue degen-
eration via different mechanisms, such as apoptosis as in
Parkinson’s and Alzheimer’s diseases and aging in general.
The main cellular mechanisms effectively controlling pro-
tein homeostasis in youth and healthy adulthood are: (1) the
molecular chaperones, acting as aggregate unfolding and
refolding enzymes, (2) the chaperone-gated proteases, act-
ing as aggregate unfolding and degrading enzymes, (3) the
aggresomes, acting as aggregate compacting machineries,
and (4) the autophagosomes, acting as aggregate degrading
organelles. For unclear reasons, these cellular defences be-
come gradually incapacitated with age, leading to the onset
of degenerative diseases. Understanding these mechanisms
and the reasons for their incapacitation in late adulthood is
key to the design of new therapies against the progression
of aging, degenerative diseases and cancers.
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Cellular youth, immortality, aging and
death
This review examines the crossroad between protein
homeostasis, aging and the onset of degenerative diseases
associated with protein aggregation. It addresses the pos-
sible links between aging and the efficacy of different pro-
tein folding and degradation machineries that can repair or
eliminate toxic misfolded proteins in healthy young cells
and also in immortalised cancer cells, but for unclear reas-
ons become defective in old cells, leading to cell death and
diseases.
A global snapshot analysis of the Earth’s biosphere would
show that the overwhelming majority of living cells are
neither dividing nor growing. Environmental resources are
generally limiting and, consequently, only a minority of
organisms may occasionally undergo exponential growth.
While being very much alive, the remaining organisms
maintain a quiescent renewable life style, in which only
minimal energy-consuming tasks are being carried out to
maintain steep ion gradients across membranes and, as time
passes, to replace stress-worn damaged macromolecules.
Life, however, can be exposed to sharp variations of envir-
onmental conditions, especially under terrestrial continent-
al climates, far from the buffering effects of large bodies of
water. Lipids, polypeptides and, to a lesser extent, polynuc-
leotides and polysaccharides, are sensitive to swift changes
in abiotic environmental cues, such as heat, cold, dehydra-
tion, ultraviolet light, the formation of reactive oxygen spe-
cies, etc. Under heat stress, for example, the hydrophobic
cores of organic macropolymers, such as membranes and
soluble protein complexes, may transiently melt and form
instead stable misfolded structures, which are biologically
inactive [1].
The process of cellular aging tightly correlates with a gen-
eral decrease in the efficiency of various cellular repair
mechanisms to prevent damage, repair or replace damaged
macromolecules, as they form with time, under various
stresses. Yet, even without stress, unicellular organisms,
such as budding yeast, may undergo age-associated
changes, ultimately leading to cell death [2]. Hence, with
increasing budding events, the protein homeostasis ma-
chineries of the mother cells undergo a decline of quality.
They gradually become defective at preventing the toxic
aggregation of proteins and at processing damaged struc-
tures in proteins [3]. Further, they show modifications and
substantial variations of cellular and vacuolar morpholo-
gies on their path to death, and they gradually fail to de-
grade and replace chemically damaged proteins and poly-
nucleotides [4–6].
Aging may not only result from the functional decline of
the cellular protein repair and degradation machineries. An
age-dependent decline of DNA repair enzymes can also
produce mutations, such as double strand breaks, that can
directly trigger apoptotic signals [7] or, less directly, un-
leash carcinogenesis or induce the formation of cytotox-
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ic misfolded protein aggregates, leading to the onset of
progressive degenerative diseases and death. Impressively,
sequencing of individual neuron nuclei from a 15-year-
old human brain revealed that over 1500 new single so-
matic mutations took place during brain development and
differentiation. The mutations were predominantly in cod-
ing regions of genes involved in nervous system develop-
ment and mature neuronal function, suggesting a “use it
and lose it” scenario, in which the very genes that were
used for the function of a neuron were those that became
most damaged during the short lifetime of that neuron lin-
eage [8]. It is thus not unlikely that new mutations in vari-
ous differentiating neuron lineages that would render pro-
teins more aggregation-prone could sooner or later over-
whelm the neuron’s defences against cytotoxic aggregates
and prompt apoptosis and tissue loss, and cause degenerat-
ive diseases.
In lower vertebrates such as the salamander, tissue regen-
eration depends on the ability of differentiated adult cells
to undergo reprogramming and become pluripotent again,
to regenerate whole amputated limbs [9]. Similarly, when
fully differentiated, growth-arrested plant cells are artifi-
cially disconnected from their original tissue, some cells
may spontaneously revert to being undifferentiated totipo-
tent stems cells, which, in the presence of appropriate hor-
mones, can regenerate into whole plant clones [10]. Adult
mammals, however, are composed mostly of terminally
differentiated cells that cannot de-differentiate into stem
cells and are therefore mortal. Only few pluripotent stem
cells are maintained, for example the germline cells, which
are immortal by virtue of their optimal capacities to repair
stress-damaged macromolecules or eliminate and promptly
replenish them [6, 11].
The process by which cells can control the rate of syn-
thesis, folding and assembly of polypeptides into functional
proteins and maintain their activity under various stresses
for a well-defined time before they must become degraded
by controlled proteases and be replaced by new polypep-
tides, is called protein homeostasis, or proteostasis [12].
Evidence that terminally differentiated cells, rather than be-
coming simply defective in protein homeostasis, are being
actively repressed from being effective in protein homeo-
stasis, comes from a Caenorhabditis elegans model for
age-dependent toxic polyglutamine aggregation. Mutant
nematodes that have arrested germline cells or that are
devoid of oocytes or sperm cells accumulate toxic protein
aggregates and develop the disease much later and live
significantly longer than fertile nematodes [13, 14]. This
indicates that an inhibitory signal, probably of hormonal
nature, is being sent from the germline cells, which are
immortal, to repress the protein homeostasis mechanisms
of the nonreproductive cells, which consequently become
mortal [13, 15].
Protein misfolding and cellular
mechanisms to maintain protein
homeostasis
When a soluble protein is rendered labile by mutations and
is exposed to various stresses, it may transiently unfold
and uncommonly expose hydrophobic residues to the hy-
drophilic surroundings (fig. 1). It is then thermodynam-
ically compelled to seek an alternatively stable misfolded
conformation lacking biological activity, which is generally
enriched in non-native β-sheets with partially exposed hy-
drophobic surfaces [16, 17]. Depending on their concen-
tration, several stress-misfolded polypeptides may further
generate intermolecular associations, leading to stable in-
soluble high-order oligomers, commonly termed aggreg-
ates. Small soluble aggregates have been reported to alter
membrane integrity, as a result of their exposed hydro-
phobic residues, by different mechanisms such as the spon-
taneous assembly of pore-forming annular oligomers [18,
19] or direct damaging punctures by the actively growing
amyloid fibrils. Ensuing plasma membrane leakages and
mitochondrial depolarisations lead to the aberrant activa-
tion of proapoptotic pathways [20, 21].
Amyloid fibrils and tangles are formed by normally soluble
proteins, which misfold and assemble to form insoluble
fibres that are resistant to degradation. Moreover, in the
cell, the disordered aggregates and the more compact pro-
tofibrils and tangles can interfere with the cytoskeleton,
enhance oxidative stress and, importantly, impair the pro-
tein repair and clearance mechanisms [22]. Furthermore,
protein aggregates can lure other labile native proteins to
misfold and aggregate as well. As with microcrystal seeds
inducing the formation of large protein crystals, minute
amounts of preformed aggregated proteins can act as seeds
(which may be formed by the physical disruption of large
aggregates, such as amyloid fibrils) catalysing the forma-
Figure 1
Proteins have an eventful life between birth on the ribosome
and death by degradation. Nascent polypeptides with exposed
hydrophobic residues (yellow) may spontaneously fold to the native
state (step 1) with most hydrophobic residues forming a stable
hydrophobic core. Stresses may cause their partial unfolding and
misfolding with exposed hydrophobic residues (step 2) that can
specifically bind (step 3) the hydrophobic surfaces (yellow) on
unfolding chaperones (deep grey) and unfold. Following unfolding,
some polypeptides can be released (step 4) to spontaneously
refold to the native state (step 5). Alternatively, over-sticky unfolded
polypeptides can be funnelled into the proteolytic chamber (red
triangles) of a protease that is associated with the chaperone (step
6) and degraded into small peptides and by peptidases into amino
acids to be reused in de novo protein synthesis.
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tion first of disordered, then of increasingly ordered com-
pact protein aggregates and fibrils. This prion-like beha-
viour may happen not only in the case of the infective
agent responsible for transmissible spongiform encephalo-
pathy, PrPsc [23], but with other metastable protein spe-
cies, such as α-synuclein in Parkinson’s disease [24, 25],
tau and amyloid-β (Aβ) peptides in Alzheimer’s diseases
[26, 27], that naturally maintain an equilibrium between
natively unfolded, partially unfolded and misfolded states
[28]. Although Parkinson’s and Alzheimer’s diseases are
multifactorial conditions, the presence in specific neural
tissues of diffuse aggregates that may further evolve into
being very stable amyloids and highly ordered fibres in
and outside cells is a hallmark of these degenerative dis-
eases. Moreover, the artificial overexpression of specific
aggregation-prone proteins can, in part, recapitulate the
symptoms of these human diseases in various animal mod-
els [29, 30].
There is strong evidence that the soluble disordered ag-
gregated oligomers of the neurodegeneration-associated
proteins, which are among the earliest intermediates of pro-
tein misfolding pathways, are also the most toxic species
for the cells. Thus, Aβ dimers can impair synaptic activ-
ity more efficiently than larger complexes [31] and small
PrPsc complexes can infect naïve mice more efficiently
than large PrPsc fibrils [32]. Moreover, studies in mod-
el organisms showed that the formation of high molecular
weight aggregates can reduce toxicity, suggesting that act-
ive condensation of the disordered aggregates is an effect-
ive mechanism to reduce toxicity [33].
Noticeably, under various stresses and because of heavy
metal poisoning, small soluble aggregated seeds can form
and further promote the aggregation of other proteins. Even
substoichiometric amounts of heavy metal ions, which can
directly cause the misfolding of only a few polypeptides
can, by way of prion-like seed-induced aggregation, ac-
celerate the aggregation of a large molar excess of labile
proteins, although most of them cannot physically interact
with the traces amounts of toxic heavy metal ions [34].
Hence, the presence of sub-stoichiometric amounts of ag-
gregated seeds can affect equilibria in various populations
of stress-labile native proteins, luring them to become
stable toxic aggregates [35]. The intracellular prionoid be-
haviour of such misfolded proteins, which escaped cellular
quality control, may, upon cell lysis, propagate to neigh-
bouring cells and tissues [36].
At the physiological level, the stress- and mutation-induced
formation and the possible propagation of various misfol-
ded protein conformers in animal cells are closely associ-
ated with the formation of reactive oxygen species (ROS),
which in animals is in turn known to trigger apoptosis,
tissue inflammation and, ultimately, cell death and tissue
loss [37–39]. Until the end of the 20th century, ROS were
thought to be the direct cause of cellular damage, leading to
cell death and tissue loss in aging animals, and of the late-
age onset of degenerative diseases [40]. But recent findings
indicate that the mutual relations between ROS and viab-
ility are more complex than initially thought. On the one
hand, low levels of ROS can extend the lifespan of nemat-
odes [41]. On the other hand, experimental evidence from
suppressor mutations of ROS-producing Arabidopsis plant
mutants showed that very high ROS levels are not cyto-
toxic [42]. Likewise, whereas the deletion of all five su-
peroxide dismutase-encoding genes of C. elegans sensit-
ised the nematodes to oxidative stress, it did not affect their
lifespan [43]. Although a systematic analysis of ROS-me-
diated apoptotic signals has not been performed in all cases
where toxic protein aggregates are the apparent cause for
programmed cell death and tissue loss, it is tempting to
speculate that in eukaryotes, ROS could act as general me-
diators of inexplicably counterproductive apoptotic signals,
leading to protein aggregation-induced cell death [44].
Whether all ROS-mediated or not, Aβ aggregation outside,
and tau aggregation inside neuronal cells strongly correlate
with Alzheimer’s disease; huntingtin aggregation with
Huntington’s disease; α-synuclein aggregation with Parkin-
son’s disease; ataxin aggregation with amyotrophic later-
al sclerosis [45] and PrPsc aggregation with Creutzfeldt-
Jakob disease [23].
Although all aggregated proteins tested seem to carry some
degree of prionoid properties, catastrophic infectious self-
feeding protein aggregations seldom occur in young cells,
with the noticeable exception of PrPsc prions that may
cause childhood death from kuru disease within months of
ingestion [46]. This relative resistance of young naive cells
and of old immortalised cancer cells to the cytotoxic accu-
mulation of misfolded proteins can be attributed to effect-
ive mechanisms to suppress ROS, such as increased levels
of ascorbate peroxidase, and to protective carotenoids, as
well as to the presence of a very effective network of mo-
lecular chaperones, which can accumulate to form up to
10% of the total protein mass of cancer cells [47]. Many
conserved families of molecular chaperones, HSP110,
HSP100, HSP70, HSP60 and possibly also HSP90, share
the ability to recognise and bind with high affinity to ex-
posed hydrophobic patches on the surfaces of misfolded
and aggregated proteins. They can use the energy of bind-
ing and also of adenosine triphosphate (ATP) hydrolysis
to forcefully unfold stable misfolded secondary structures
such as wrong β-sheets [48–51], thereby converting them
into low-affinity native proteins that do not oddly expose
hydrophobic residues.
The first molecular chaperones were discovered in a screen
for Escherichia coli mutants that failed to assemble phage
heads and tails [52]. Bacteria with missense mutations in
the genes encoding for GroES, GroEL, DnaK, DnaJ, and
GrpE failed to develop mature T4 and lambda phages, a
phenotype that was systematically accompanied by an in-
creased sensitivity to mild heat-shock temperatures. Even
at a permissive temperature, the mutants had impaired an-
tibiotic resistance and they accumulated insoluble protein
aggregates [53, 54, 55], suggesting that the chaperone net-
work could easily become overwhelmed by a stress, such
as viral infection or mild heat shock. The chaperone net-
work of eukaryotic cells can also become overwhelmed, for
example in rapidly growing tissues or in specialised tissues
that need to handle properly the massive and timely syn-
thesis and assembly of particular protein complexes, such
actin and tubulin complexes in sperm cells [56], or actin
and myosin complexes in muscle sarcomeres [57]. Thus,
different healthy and cancerous mammalian tissues may
contain quite different levels of various types of chaper-
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ones, totalling 5% of the entire protein mass in naive rat
hepatocytes (Finka and Goloubinoff, unpublished results),
up to 10% in HeLa cells [47], in correlation with their abil-
ity to withstand many genetic aberrations and survive treat-
ments with abiotic stresses, radiation and chemotherapeutic
drugs [42, 58]. It is therefore not surprising that many chap-
erones are also heat-inducible and are generally, although
inadequately, called heat-shock proteins (HSPs). Under a
mild feverish condition of 4 h at 41 °C, human culture cells
(Jurkat) may accumulate up to 4% of their total mass in
the form of new HSPs, half of which are the three core
cytoplasmic chaperones HSC70 (HSPA8), HSP90AA1 and
HSP90AB1. This occurs at the cost of an across-the-board
mild degradation of hundreds of housekeeping enzymes,
such as glyceraldehyde-3-phosphate dehydrogenase, and
structural proteins, such as the ribosomal proteins [59].
By virtue of their ability to prevent protein aggregation
during stress, and to unfold and disaggregate structurally
damaged proteins after stress, the various members of the
chaperone network can maintain optimal cellular protein
homeostasis, at least in youth [45]. Notably, whereas ex-
vivo naïve mammalian cells expressing relatively low
chaperone levels die after several cell divisions, immortal
cancer cells in culture express high chaperone levels [47,
60, 61]. This correlation suggests that the abnormal iso-
thermal constitutive upregulation of specific chaperones in
cancer cells might arrest programmed cell death. This was
demonstrated in the case of HSP70 (HSPA1A), which is
virtually absent in unstressed normal cells but strongly ac-
cumulates under various stresses [59], including heat and
treatments with chemotherapy drugs [58]. At variance with
the inducible HSP70, which can specifically block apop-
tosis; HSC70 (HSPA8), which shares 90% homology with
HSP70, cannot block apoptosis. It is constitutively ex-
pressed at very high levels, about 0.5–1% of the total pro-
tein mass of nonstressed mammalian cells [59]. It can act
both on stress-misfolded proteins and on native substrates,
such as clathrin cages to be recycled into free triskelions
[62]. It is important to note that in some cases the over
expression of specific folding enzymes, such as peptidyl-
prolyl cis-trans isomerases, could be deleterious. For ex-
ample, the deletion of the HSP90 co-chaperone FKBP51,
was shown to protect model mice from the toxicity of tau
aggregation, and that over-expression of FKBP51 can pre-
vent tau degradation by the proteasome, thereby promoting
the conversion of tau into cytotoxic tangles [63].
Despite these very large amounts of chaperones, there are
physiological and stressful situations where the chaperone
network can become limiting. Hence, when a thermo-sens-
itive aggregation-prone mutant protein is expressed at a
permissive low temperature, it may fold and function cor-
rectly in C. elegans muscle cells. Yet when a second
aggregation-prone protein with a polyglutamine tract ex-
ceeding 35 glutamines is co-expressed, the first mutant
protein can become inactive and aggregate even at low
permissive temperatures, indicating that the chaperone net-
work is overwhelmed by the expressed polyQ protein [64].
An increase in the aggregate load of the cell can also be at-
tained by specific proteasome inhibitors, or by applying a
stress, or by the formation of prion-like misfolding species
that propagate within and among cells [65, 66].
The hierarchy of the protein
homeostasis mechanisms in the cell
At the ribosomal exit, de novo synthesised polypeptides
first encounter the highly crowded cellular environment,
ranging from 100 mg/ml to 350 mg/ml of proteins for the
cytosol of eukaryotes and bacteria, respectively. High pro-
tein crowding may increase the propensity of the emerging
unfolded polypeptides to form wrong secondary structures,
in particular aggregation-prone β-sheets with hydrophobic
residues abnormally exposed to the hydrophilic cytosol
[67]. Trigger factor and DnaK in the case of bacteria, and
heat-shock cognate (HSC)70, zuotin and HSPA14 in the
case of eukaryotes, are molecular chaperones that can be-
come transiently anchored to the ribosome exits, in the ex-
pectation of binding exposed emerging hydrophobic seg-
ments [67, 68]. Upon binding, the chaperones may prevent
misfolding, actively unfold [69] and, upon dissociation,
promote the proper folding of an emerging polypeptide into
its native state, in the structure of which most of the hy-
drophobic residues (fig. 1, yellow) are properly internal-
ised (fig. 1 step 1). A stress, such as heat shock, may par-
tially melt the hydrophobic core of native proteins (fig.
1 step 2) and lead to the formation metastable misfolded
structures, which are enriched with wrong β-sheets that
expose some hydrophobic residues to water and lead to
the spontaneous assembly of oligomeric ensembles of mis-
folded polypeptide chains, generally called aggregates. In
the cell, however, the exposed non-native hydrophobic sur-
faces on the misfolded polypeptide species can bind with
high affinity to specific exposed hydrophobic surfaces at
the surfaces of molecular chaperones, such as the upper in-
ner rim of the chaperonin cavities of chaperonin contain-
ing t-complex protein 1 (CCT) and GroEL, or on the spe-
cific protein-binding sites in the protein-binding domains
of HSP40 and HSP70 [70]. Mere hydrophobic binding of
metastable non-native misfolded species to the stable nat-
ive chaperone molecule surfaces may already cause some
local unfolding of the misfolded polypeptide substrate (fig.
1 step 3). Concerted ATP-fuelled motion of domains within
the chaperones may further pull apart and unfold bound
misfolded segments in between or distal to the chaperone
binding segments, thereby allowing longer segments of
the newly unfolded polypeptide to seek more native-like
conformations, ultimately leading to dissociation from the
chaperone (fig. 1 step 4) and native refolding in solution
(fig. 1 step 5). If the chaperone-bound partially-unfolded
polypeptide fails to dissociate within a biologically rel-
evant time, ATP hydrolysis can be recruited to forcefully
change the hydrophobic nature of the over-sticky chaper-
one binding sites into hydrophilic, as in the case of GroEL
and CCT [71], thereby forcefully evicting the over-sticky
unfolded intermediates and allowing them to fold to the
native state. Thus, chaperones can act as polypeptide-un-
folding catalysts accelerating the conversion of high-af-
finity metastable misfolded substrates, such as toxic pro-
tofibrils, or alternatively folded substrates such as clathrin
cages [62], into stable, low-affinity native products [50].
However, mutations or various external stresses can cause
irreversible damage to polypeptides, such as early stop
codons, or chemical damage, such as glycation, oxidation
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or the hydrolysis of peptide bonds. In such cases, unfolding
chaperones cannot lead to the native state.
To avoid chaperone stalling by over-sticky intermediates,
different evolutional variants of unfolding chaperones are
found in association with a specific protease into which
irrecoverably damaged polypeptides can be funnelled to
be degraded into small peptides (fig. 1 step 6). For ex-
ample, ClpA is an ATP-fuelled cylindrical hexameric un-
folding/disaggregating ring chaperone forming a complex
with ClpP, which is a cylindrical heptameric protease. The
ClpA-unfolded polypeptides may thus be unidirectionally
funnelled into the ClpP chamber where they are specific-
ally hydrolysed. ClpX and HslU are other ClpA-related un-
folding chaperones that also form noncovalent complexes
with specific ring-shaped proteases, ClpP and HslV, re-
spectively. Different unfoldase-protease associations are
observed in the case of Lon and FtsH, which are both
hexameric ATPase cylinders, where each polypeptide has
an N-terminal domain acting as the ATP-fuelled unfolding/
disaggregating chaperone and a C-terminal domain acting
as a chaperone-gated degrading protease ring [72] (fig. 1
step 6). The peptides that are released from these proteases
may in turn be further hydrolysed by specific peptidases
such as the tricorn aminopeptidases [73] into free reus-
able amino acids for resynthesis of new unaltered poly-
peptides. This latter unfolding→degradation→resynthesis
pathway (fig. 1 steps 3, 6, 1) is estimated to be at least three
orders of magnitude more costly, in terms of hydrolysed
ATP molecules, than the first unfolding→refolding path-
way (fig. 1 step 3–5) [48]. Interestingly, sequence-wise and
structurally, ClpA has a very close homologue called ClpB
(HSP104 in yeast and HSP101 in plants), which does not
form a complex with a protease. Instead, ClpB acts in close
collaboration with another unfolding chaperone, HSP70
(DnaK), through a special M-domain. Together they drive
the unfolding and disaggregation of large stable proteins
aggregates into native proteins [74–77]. It is tempting to
speculate that the evolutionary scenario was that of an
initial unfolding chaperone-protease carrying both refold-
ing and degrading functions, which later specialised into
the ClpA-ClpP unfoldase-protease and the ClpB-DnaK
unfoldase-refoldase. These two diverging activities have
been observed in complexes of polypeptides with two dis-
tinct segments: an N-terminal ATP-dependent unfoldase
domain followed by a C-terminal protease domain. Inter-
estingly, the prokaryotic and organellar AAA+ (ATPase as-
sociated with diverse cellular activities) protein Lon can
process bound substrates at markedly varying rates; under
some conditions, it may function as an ATP-dependent
chaperone that mostly refolds misfolded proteins and under
other conditions, as an ATP-independent protease that
mostly degrades misfolded proteins [72, 78]. A similar du-
ality has been observed in DegP proteins, which may func-
tion as both ATP-independent chaperones that mostly re-
fold misfolded proteins and, under other conditions, as a
protease that mostly degrades misfolded proteins [79]. The
decision between protein repair and recycling could de-
pend, for example, on the time spent by the polypeptide on
chaperone surface. Whereas a short stay would increase the
chances for the released polypeptide to refold in solution to
the native state, a longer stay would increase its chances to
become translocated and hydrolysed by the nearby proteo-
lytic sites (fig. 1 step 6, red triangles).
When over-sticky misfolded polypeptides resist unfolding
and hydrolysis, they act as competitive inhibitors of the
chaperone and/or proteases to which they are bound, pre-
venting the progressive conversion of other misfolded
polypeptides. Chaperone-mediated autophagy in eukaryot-
ic cells happens when the stalling polypeptides containing
a specific N-terminal lysosomal targeting signal docks the
whole substrate+chaperone/protease complex onto
lysosome-associated membrane protein 2 (LAMP-2A)
[80]. Substrate binding triggers the formation of LAMP-2A
multimers that act as a translocation complex to the lyso-
somes. Whereas the translocation would liberate the stalled
cytoplasmic chaperone complex to act again as an unfol-
dase (fig. 2 step 1), the formerly over-sticky chaperone-res-
istant polypeptides would be specifically delivered and de-
graded by the lysosomal proteases [81]. Other chaperone-
stalled misfolded proteins, especially those lacking the
KFERQ pentapeptide, can form large compact detergent-
insoluble aggresomes by transporting the misfolded pro-
teins, most of which are ubiquitinated, along microtubules
to a region near the nucleus [82]. Aggresome formation is
accompanied by a redistribution of the intermediate fila-
ment of vimentin to form a cage surrounding a pericentri-
olar core of the aggregated proteins (fig. 2 step 2) [83].
Whereas the ubiquitinated polypeptides may then be de-
graded by the proteasome (fig. 2 step 3), there is still a pos-
sibility for nonubiquitinated undamaged polypeptides to be
refolded to the native state assisted by ATP-fuelled disag-
gregating chaperones such as HSP110-HSC70 [45, 84, 85]
(fig. 2 step 4).
Aggresomes are only one type of cellular deposition sites
among others described as insoluble protein deposits
(IPODs), juxta-nuclear quality control compartment
(JUNQ) [86], also named intranuclear quality control com-
partment (INQ) [87] and the endoplasmic-reticulum-to-
Golgi intermediate compartment (ERGIC) [88]. It should
be noted that once such a late stage of protein clearance has
been reached, in which toxic conformers are already effect-
ively compacted into less toxic cellular deposits, overdue
attempts to reduce protein misfolding toxicity by express-
ing artificially a powerful disaggregating chaperone, might
produce counterproductive effects. Illustrating the possible
contradictory actions of a chaperone at different concen-
trations on already formed compact aggregates, Shorter
and Lindquist showed that above physiological levels of
HSP104 in yeast could dramatically decrease the cellular
levels of SUP35 prions, yet without completely curing
them, whereas, HSP104-knockout mutants were fully res-
istant to SUP35 infection and propagation [89].
Thus, at the later stages of protein homeostasis where least
toxic protein deposits are already formed, a more advant-
ageous path would be to form an autophagosome around
the intracellular protein deposits, to then be fused with the
lysosome in a process called macro-autophagy (fig. 2 step
5). The peptides that are produced by the lysosome and the
proteasome can be further hydrolysed by peptidases into
amino acids which will be reused for protein synthesis.
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Figure 2
Compaction and degradation of irreversibly damaged
polypeptides by the lysosome and the proteasome. When an
irreversibly damaged polypeptide is over-sticky and is stalling an
unfolding chaperone such as HSC70, the chaperone can target the
polypeptide to the lysosome surface (step 1), where it will be
specifically imported by specific transporters and degraded by
chaperone-mediated autophagy. Alternatively, it may be compacted
by the aggresome machinery (step 2), ubiquitinated, unfolded and
degraded by the proteasome (step 3). When not ubiquitinated, the
polypeptide may be actively disaggregated by unfolding
chaperones and reach the native state (step 4). Alternatively,
proteasome-resistant aggresomes may become enveloped by
autophagosome membranes and imported into the lysosome to be
degraded by autophagy (step 5).
Conclusion
Aging is a natural and necessary degenerative process of
the somatic cells, leading to death. Young embryonic,
germline and cancer cells are potentially immortal by vir-
tue of their ability to massively produce optimal defences
to protect, repair and replace their delicate macromolec-
ules, such as DNA, proteins and lipids that may accumulate
structural and chemical damages, as time passes. Depend-
ing on the tissues, the sum of masses of the molecular chap-
erones, co-chaperones, of chaperone-gated proteases, and
of the proteins involved in micro- and macro-autophagy
may reach 20% of the total proteins [47]. Furthermore, so-
matic cells may need to invest in cellular defences, albeit
only for a defined period of time, mostly before and less
beyond, reproductive age [13, 15].
Many questions remain unanswered, such as what is the
nature of the signal that is apparently sent from the
germline cells to repress the expression of cellular defences
in somatic cells, and causing protein homeostasis collapse
and death? Another question is what distinguishes young
embryonic cells with optimal quality control mechanisms
that are growing and differentiating into healthy pre-adult
individuals from cancer cells with seemingly optimal qual-
ity control mechanisms that are growing into unhealthy tu-
mours? Answers may lead to the development of genetic
or pharmacological treatments to reactivate specific
unfolding-disaggregating chaperones, co-chaperones and
proteases, to retard the onset of protein-misfolding diseases
and aging without causing cancers. This knowledge could
also lead to the development of new anticancer drugs,
HSP70 and HSP90 inhibitors in particular, that would in-
duce the collapse of proteostasis and apoptosis specifically
in rapidly dividing and growing cancer cells and not in
healthy aging quiescent cells [90].
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Figures (large format)
Figure 1
Proteins have an eventful life between birth on the ribosome and death by degradation. Nascent polypeptides with exposed hydrophobic
residues (yellow) may spontaneously fold to the native state (step 1) with most hydrophobic residues forming a stable hydrophobic core.
Stresses may cause their partial unfolding and misfolding with exposed hydrophobic residues (step 2) that can specifically bind (step 3) the
hydrophobic surfaces (yellow) on unfolding chaperones (deep grey) and unfold. Following unfolding some polypeptides can be released (step 4)
to spontaneously refold to the native state (step 5). Alternatively, over-sticky unfolded polypeptides can be funnelled into the proteolytic chamber
(red triangles) of a protease that is associated with the chaperone (step 6) and degraded into small peptides and by peptidases into amino acids
to be reused in de novo protein synthesis.
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Figure 2
Compaction and degradation of irreversibly damaged polypeptides by the lysosome and the proteasome. When an irreversibly
damaged polypeptide is over-sticky and is stalling an unfolding chaperone such as HSC70, the chaperone can target the polypeptide to the
lysosome surface (step 1), where it will be specifically imported by specific transporters and degraded by chaperone-mediated autophagy.
Alternatively, it may be compacted by the aggresome machinery (step 2), ubiquitinated, unfolded and degraded by the proteasome (step 3).
When not ubiquitinated, the polypeptide may be actively disaggregated by unfolding chaperones and reach the native state (step 4).
Alternatively, proteasome-resistant aggresomes may become enveloped by autophagosome membranes and imported into the lysosome to be
degraded by autophagy (step 5).
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